Literature DB >> 12186208

Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy.

Curtis J Donskey1, Claudia K Hoyen, Sarbani M Das, Marion S Helfand, Michelle T Hecker.   

Abstract

OBJECTIVE: To test the hypothesis that antibiotic therapy may promote recurrence of vancomycin-resistant Enterococcus (VRE) stool colonization in patients who have previously had three consecutive negative stool cultures obtained at least 1 week apart.
DESIGN: One-year prospective cohort study examining the effect of antibiotic therapy on recurrence and density of VRE stool colonization in patients who have cleared colonization. Pulsed-field gel electrophoresis (PFGE) was performed to determine whether recurrent VRE strains were the same clone as the previous colonizing strain.
SETTING: A Department of Veterans Affairs medical center including an acute care hospital and nursing home. PATIENTS: All patients with at least one stool culture positive for VRE who subsequently had three consecutive negative stool cultures obtained at least 1 week apart.
RESULTS: Of the 16 patients who cleared VRE colonization, 13 received antibiotic therapy during the study period. Eight (62%) of the 13 patients who received antibiotics developed recurrent high-density VRE stool colonization (range, 4.9 to 9.1 log10 colony-forming units per gram) during a course of therapy. Five patients had VRE strains available for PFGE analysis; recurrent strains were unrelated to the prior strain in 3 patients, closely related in 1 patient, and indistinguishable in 1 patient.
CONCLUSIONS: Antibiotic therapy may be associated with recurrent high-density VRE stool colonization in many patients who have previously had three consecutive negative stool cultures. These patients should be screened for recurrent stool colonization when antibiotic therapy is administered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12186208     DOI: 10.1086/502081

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  14 in total

1.  Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage.

Authors:  James A McKinnell; Danielle F Kunz; Eric Chamot; Mukesh Patel; Rhett M Shirley; Stephen A Moser; John W Baddley; Peter G Pappas; Loren G Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2012-05-14       Impact factor: 3.254

2.  Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type.

Authors:  E M Mascini; K P Jalink; T E M Kamp-Hopmans; H E M Blok; J Verhoef; M J M Bonten; A Troelstra
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

3.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

4.  Characterizing an outbreak of vancomycin-resistant enterococci using hidden Markov models.

Authors:  E S McBryde; A N Pettitt; B S Cooper; D L S McElwain
Journal:  J R Soc Interface       Date:  2007-08-22       Impact factor: 4.118

5.  Predicting clearance of colonization with vancomycin-resistant Enterococci and methicillin-resistant Staphylococcus aureus by use of weekly surveillance cultures.

Authors:  Charmaine M Huckabee; W Charles Huskins; Patrick R Murray
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

6.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

7.  Prevalence and risk factors for asymptomatic Clostridium difficile carriage.

Authors:  Faisal Alasmari; Sondra M Seiler; Tiffany Hink; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Clin Infect Dis       Date:  2014-04-21       Impact factor: 9.079

8.  Do Inpatient Antimicrobial Stewardship Programs Help Us in the Battle Against Antimicrobial Resistance?

Authors:  Sara Y Tartof; Lie Hong Chen; Yun Tian; Rong Wei; Theresa Im; Kalvin Yu; Gunter Rieg; Zoe Bider-Canfield; Frances Wong; Harpreet S Takhar; Lei Qian
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

9.  Rapid curbing of a vancomycin-resistant Enterococcus faecium outbreak in a nephrology department.

Authors:  Aude Servais; Lucile Mercadal; Florence Brossier; Marcia Venditto; Belkacem Issad; Corinne Isnard-Bagnis; Gilbert Deray; Jérôme Robert
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 8.237

Review 10.  Early diagnosis of resistant pathogens: how can it improve antimicrobial treatment?

Authors:  Sanjay Bhattacharya
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.